However, Angelucci et al. measured BDNF serum levels in Alzheimer’s disease patients with several degrees of severity, mild cognitive impairment and healthy subjects, and found that the observed BDNF serum levels increase was neither dependent on treatment nor on disease severity. The gene discussed is BDNF; the disease is Cognitive impairment.